AI/ML real-world data study to monitor outcomes when patients switch between complex generics and reference drugs
This opportunity would fund teams to develop and test an AI/ML-based real-world data model for post-market surveillance of complex generic drug products. The goal is to compare patient clinical outcomes between complex generics and their corresponding reference listed drugs, helping regulators detect potential therapeutic equivalence issues efficiently. Note: this is labeled “Clinical Trial No…
Source
Award
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers